New FDA group to simplify oversight of product claims

WASHINGTON: The Food and Drug Administration is going to streamline how it regulates the promotional activities of medical products, launching a new group to coordinate policies and communications across its eight centers and offices.

WASHINGTON: The Food and Drug Administration is going to streamline how it regulates the promotional activities of medical products, launching a new group to coordinate policies and communications across its eight centers and offices.

Acting Commissioner Lester Crawford detailed plans for the inter-center group August 2 at the National Press Club's "Newsmaker Luncheon," where he also outlined several goals for the next six months.

"We recognize issues in promotion that have been of concern," Crawford said, citing "outdoor advertising, comparative claims, and implied claims."

These concerns arose with "the rapid growth in DTC advertising," said Christine Parker, public affairs specialist.

The group also will provide a unified voice for communicating with the public about these issues, Crawford added. It also will regulate enforcement efforts.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Would you like to post a comment?

Please Sign in or register.